Zahi Touma
Zahi Touma
Associate Professor of Medicine, University of Toronto
Verified email at
Cited by
Cited by
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ...
Arthritis & rheumatology 71 (9), 1400-1412, 2019
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2 …
RF Van Vollenhoven, BH Hahn, GC Tsokos, CL Wagner, P Lipsky, ...
The Lancet 392 (10155), 1330-1339, 2018
Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta‐analysis of observational studies
A Polachek, Z Touma, M Anderson, L Eder
Arthritis care & research 69 (1), 67-74, 2017
Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis
Z Touma, DD Gladman, MB Urowitz, J Beyene, EM Uleryk, PS Shah
The Journal of rheumatology 38 (1), 69-78, 2011
Cardiac sarcoidosis responding to monotherapy with infliximab
I Uthman, Z Touma, M Khoury
Clinical rheumatology 26 (11), 2001-2003, 2007
Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments
Z Touma, DD Gladman
Lupus science & medicine 4 (1), 2017
TNF polymorphisms in patients with Behcet disease: a meta-analysis
Z Touma, C Farra, A Hamdan, W Shamseddeen, I Uthman, H Hourani, ...
Archives of medical research 41 (2), 142-146, 2010
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation
Z Touma, MB Urowitz, D Ibañez, DD Gladman
Lupus 20 (1), 67-70, 2011
Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment
Z Touma, MB Urowitz, D Ibañez, DD Gladman
The Journal of rheumatology 41 (4), 688-697, 2014
SLEDAI-2K for a 30-day window
Z Touma, MB Urowitz, DD Gladman
Lupus 19 (1), 49-51, 2010
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
Z Touma, DD Gladman, D Ibañez, MB Urowitz
The Journal of rheumatology 38 (9), 1898-1905, 2011
Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans
R Shinde, K Hezaveh, MJ Halaby, A Kloetgen, A Chakravarthy, ...
Nature immunology 19 (6), 571-582, 2018
How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new …
M Mosca, KH Costenbader, SR Johnson, V Lorenzoni, GD Sebastiani, ...
Arthritis & Rheumatology 71 (1), 91-98, 2019
Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50
Z Touma, DD Gladman, D Ibañez, MB Urowitz
The Journal of rheumatology 38 (2), 275-284, 2011
Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus
TK McGhie, P Harvey, J Su, N Anderson, G Tomlinson, Z Touma
Clin Exp Rheumatol 36 (4), 545-551, 2018
Successful treatment of cardiac involvement in dermatomyositis with rituximab
Z Touma, T Arayssi, L Kibbi, AF Masri
Joint Bone Spine 75 (3), 334-337, 2008
Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes
Z Touma, L Eder, D Zisman, J Feld, V Chandran, CF Rosen, H Shen, ...
Arthritis care & research 63 (10), 1440-1447, 2011
Oral bisphosphonates in treatment of transient osteoporosis
L Kibbi, Z Touma, N Khoury, T Arayssi
Clinical rheumatology 27 (4), 529-532, 2008
Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus
G Cramarossa, MB Urowitz, J Su, D Gladman, Z Touma
Lupus 26 (4), 365-372, 2017
Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus
AB Dua, Z Touma, S Toloza, M Jolly
Current rheumatology reports 15 (12), 1-11, 2013
The system can't perform the operation now. Try again later.
Articles 1–20